for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Vaccinex Provides Update Of Potentially Pivotal Signal Clinical Trial In Huntington's Disease

July 7 (Reuters) - Vaccinex Inc:

* VACCINEX PROVIDES UPDATE OF POTENTIALLY PIVOTAL SIGNAL CLINICAL TRIAL IN HUNTINGTON’S DISEASE

* VACCINEX INC - REMAINS ON TRACK TO COMPLETE POTENTIALLY PIVOTAL SIGNAL TRIAL IN HD WITHIN ANTICIPATED TIME FRAME

* VACCINEX INC - CONTINUES TO ANTICIPATE THAT DATABASE LOCK WILL BE COMPLETED BY SEPTEMBER

* VACCINEX INC - PRIMARY EFFICACY DATA HAS BEEN COLLECTED FROM ALL SUBJECTS WHO COMPLETED STUDY EXCEPT FOR 2 SUBJECTS

* VACCINEX INC - IDENTIFIED PRIMARY AND SECONDARY ENDPOINTS FOR TWO RANDOMIZED ARMS OF SIGNAL TRIAL Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up